Table 2.
Variables affecting the use of ART.
| Re-simulation |
|||||
|---|---|---|---|---|---|
| Value | Total | No | Yes | P-value | |
| Location | Clitoral/Periurethral | 16(72.7%) | 7(77.8%) | 9(69.2%) | 0.999 |
| Labia Minora/Majora | 6(27.3%) | 2(22.2%) | 4(30.8%) | ||
| T stage | TIb | 6(27.3%) | 3(33.3%) | 3(23.1%) | 0.658 |
| TII | 14(63.6%) | 6(66.7%) | 8(61.5%) | ||
| TIII | 2(91%) | 2(15.4%) | |||
| Lymph node dissection | No | 13(59.1%) | 4(44.4%) | 9(69.2%) | 0.384 |
| Yes | 9(40.9%) | 5(55.6%) | 4(30.8%) | ||
| BMI category | Normal | 4(18.2%) | 2(22.2%) | 2(15.4%) | 0.271 |
| Obese | 11(50.0%) | 6(66.7%) | 5(38.5%) | ||
| Overweight | 7(31.8%) | 1(11.1%) | 6(46.2%) | ||
| Grade | 1 | 1(4.5%) | 1(7.7%) | 0.999 | |
| 2 | 18(81.8) | 8(88.9%) | 10(76.9%) | ||
| 3 | 3(13.6%) | 1(11.1%) | 2(15.4%) | ||
| Age | < = 55.5 | 11(50.0%) | 4(44.4%) | 7(53.8%) | 1.000 |
| >55.5 | 11(50.0%) | 5(55.6%) | 6(46.2%) | ||
| Tumor volume | < = 30 cc | 12(54.5%) | 9(100%) | 3(23.1%) | 0.0005 |
| >30 cc | 10(45.5%) | 10(76.9%) | |||